Literature DB >> 6428763

Effects of the diuretics mannitol or acetazolamide on nephrotoxicity and physiological disposition of cisplatin in rats.

N M Osman, M P Copley, C L Litterst.   

Abstract

The anticancer drug cisplatin has been known to produce severe renal lesions characterized by high levels of blood urea nitrogen (BUN), toxic nephrosis, and platinum (Pt) retention in the kidney. The effect of IV pretreatment with acetazolamide (ACZ) 30 min before or mannitol (MAN) immediately prior to IP administration of 5 mg/kg cisplatin on Pt excretion, tissue distribution, and nephrotoxicity was investigated in male F344 rats. ACZ pretreatment reduced the cisplatin-induced nephrotoxicity, as indicated by only a slight elevation of BUN, a milder histopathologic lesion, and a more rapid recovery of renal function and structure. Although MAN-pretreated animals exhibited similar changes in BUN to ACZ-pretreated animals, the renal damage was similar to that seen in animals treated with cisplatin alone. A reduction of kidney Pt content was observed with both diuretics, although there was significantly less retention after ACZ pretreatment. The diuretic ACZ was more effective than MAN in reducing the renal lesions induced by cisplatin and it might be clinically useful in preventing cisplatin nephrotoxicity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6428763     DOI: 10.1007/bf00401449

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  17 in total

1.  The effect of diuretic pre-treatment on clinical, morphological and ultrastructural cis-platinum induced nephrotoxicity.

Authors:  D Lehane; A Winston; R Gray; Y Daskal
Journal:  Int J Radiat Oncol Biol Phys       Date:  1979-08       Impact factor: 7.038

2.  Studies on the renal excretion of salicylate in the dog.

Authors:  I M WEINER; J A WASHINGTON; G H MUDGE
Journal:  Bull Johns Hopkins Hosp       Date:  1959-11

3.  Protection of rat kidneys against HgCl2-induced acute renal failure by induction of high urine flow without renin suppression.

Authors:  G Thiel; F Brunner; P Wunderlich; M Huguenin; B Bienko; J Torhorst; L Peters-Haefeli; E J Kirchertz; G Peters
Journal:  Kidney Int Suppl       Date:  1976-10       Impact factor: 10.545

4.  Increased tissue deposition and decreased excretion of platinum following administration of cisplatin to cisplatin-pretreated animals.

Authors:  C L Litterst; V G Schweitzer
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

5.  Cisplatin metabolites: a method for their separation and for measurement of their renal clearance in vivo.

Authors:  P T Daley-Yates; D C McBrien
Journal:  Biochem Pharmacol       Date:  1983-01-01       Impact factor: 5.858

6.  Rapid determination of urea nitrogen in serum or plasma without deproteinization.

Authors:  C L Crocker
Journal:  Am J Med Technol       Date:  1967 Sep-Oct

7.  Effect of sodium thiosulfate on cis-dichlorodiammineplatinum(II) toxicity and antitumor activity in L1210 leukemia.

Authors:  S B Howell; R Taetle
Journal:  Cancer Treat Rep       Date:  1980 Apr-May

8.  Effect of a forced diuresis on the distribution and excretion (via urine and bile) of 195mplatinum when given as 195mplatinum cis-dichlorodiammineplatinum(II).

Authors:  P A DeSimone; R S Yancey; J J Coupal; J D Butts; J D Hoeschel
Journal:  Cancer Treat Rep       Date:  1979-06

9.  Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model.

Authors:  E Cvitkovic; J Spaulding; V Bethune; J Martin; W F Whitmore
Journal:  Cancer       Date:  1977-04       Impact factor: 6.860

10.  High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis.

Authors:  D M Hayes; E Cvitkovic; R B Golbey; E Scheiner; L Helson; I H Krakoff
Journal:  Cancer       Date:  1977-04       Impact factor: 6.860

View more
  3 in total

1.  Investigations on the acute and chronic nephrotoxicity of the new platinum analogue carboplatin.

Authors:  U Metz-Kurschel; E Kurschel; N Niederle; E Aulbert
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Factors affecting human autopsy kidney-cortex and kidney-medulla platinum concentrations after cisplatin administration.

Authors:  D J Stewart; C Dulberg; J M Molepo; N Z Mikhael; V A Montpetit; M D Redmond; R Goel
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

3.  Evaluation of the effect of acetazolamide versus mannitol on cisplatin-induced nephrotoxicity, a pilot study.

Authors:  Manal El Hamamsy; Noha Kamal; Naglaa Samir Bazan; Mostafa El Haddad
Journal:  Int J Clin Pharm       Date:  2018-08-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.